BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8082679)

  • 1. Hepatic myelopathy: a rare complication of portacaval shunt.
    Mendoza G; Marti-Fàbregas J; Kulisevsky J; Escartín A
    Eur Neurol; 1994; 34(4):209-12. PubMed ID: 8082679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A controlled study of therapeutic portacaval shunt in alcoholic cirrhosis.
    Rueff B; Prandi D; Degos F; Sicot J; Degos JD; Sicot C; Maillard JN; Fauvert R; Benhamou JP
    Lancet; 1976 Mar; 1(7961):655-9. PubMed ID: 73637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postshunt myelopathy.
    Bain VG; Bailey RJ; Jhamandas JH
    J Clin Gastroenterol; 1991 Oct; 13(5):562-4. PubMed ID: 1744395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acute paraparesis in chronic hepatic disease].
    Jeske J; Schädlich HJ; Sandmann J; Karbe H; Haupt WF; Karenberg A
    Nervenarzt; 1991 Feb; 62(2):130-2. PubMed ID: 1851969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A rare intrahepatic portacaval tubular shunt in a patient with spastic paraparesis.
    Ardic S; Deniz E; Arbatli M; Ardic FA; Aysun A
    Australas Radiol; 1997 May; 41(2):181-4. PubMed ID: 9153820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myelopathy in cirrhosis.
    Robinson CE; Anzarut A
    Paraplegia; 1978 May; 16(1):3-4. PubMed ID: 733284
    [No Abstract]   [Full Text] [Related]  

  • 7. Spastic paraparesis with cirrhosis of liver.
    Rab SM; Hussain SM
    Br J Clin Pract; 1985 Jun; 39(6):244-6. PubMed ID: 4041351
    [No Abstract]   [Full Text] [Related]  

  • 8. Three decades of experience with emergency portacaval shunt for acutely bleeding esophageal varices in 400 unselected patients with cirrhosis of the liver.
    Orloff MJ; Orloff MS; Orloff SL; Rambotti M; Girard B
    J Am Coll Surg; 1995 Mar; 180(3):257-72. PubMed ID: 7874335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calibrated portacaval H-graft shunt in variceal hemorrhage. Long-term results.
    Fernandez-Aguilar JL; Bondia Navarro JA; Santoyo Santoyo J; Suarez-Muñoz MA; Perez-Daga A; Ramirez Plaza C; Mera Velasco S; de la Fuente Perucho A
    Hepatogastroenterology; 2003; 50(54):2000-4. PubMed ID: 14696452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic myelopathy neurological complication of chronic liver disease: two case reports.
    Mhiri M; Ben Abdelwahed M; Dhiflaoui MA; Ben Dhia R; Gouta N; Jemni I; Baklouti R; Zakhama M; Gueddiche A; Loghmari MH; Ben Chaabene N; Safer L; Frih-Ayed M
    J Med Case Rep; 2024 Jun; 18(1):281. PubMed ID: 38880918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver function and encephalopathy after partial vs direct side-to-side portacaval shunt: a prospective randomized clinical trial.
    Capussotti L; Vergara V; Polastri R; Bouzari H; Galatola G
    Surgery; 2000 Jun; 127(6):614-21. PubMed ID: 10840355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Early and late results after portacaval shunt].
    Steegmüller KW; Fischer R
    Med Welt; 1980 Jan; 31(1):21-6. PubMed ID: 7382800
    [No Abstract]   [Full Text] [Related]  

  • 13. Analysis of nutrient hepatic blood flow after 8-mm versus 16-mm portacaval H-grafts in a prospective randomized trial.
    Rypins EB; Milne N; Sarfeh IJ
    Am J Surg; 1995 Feb; 169(2):197-200; discussion 200-1. PubMed ID: 7840379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic myelopathy as a presenting neurological complication in patients with cirrhosis and spontaneous splenorenal shunt.
    Koo JE; Lim YS; Myung SJ; Suh KS; Kim KM; Lee HC; Chung YH; Lee YS; Suh DJ
    Korean J Hepatol; 2008 Mar; 14(1):89-96. PubMed ID: 18367861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Teaching Video NeuroImages: Hepatic myelopathy: An unusual neurologic complication of hepatic encephalopathy.
    Ciarlariello VB; Fujino MVT; Almeida MD; Barsottini OGP; Pedroso JL
    Neurology; 2019 Jul; 93(3):e320-e321. PubMed ID: 31308174
    [No Abstract]   [Full Text] [Related]  

  • 16. Symposium on portal hypertension and its complications: current management. Preoperative assessment and predictors of encephalopathy.
    Huet PM; Marleau D; Viallet A; Duguay L; Tanguay S; Lavoie P
    Can J Surg; 1979 Nov; 22(6):545-8. PubMed ID: 497928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Portacaval shunt as emergency procedure in unselected patients with alcoholic cirrhosis.
    Orloff MJ; Charters AC; Chandler JG; Condon JK; Grambort DE; Modafferi TR; Levin SE; Brown NB; Sviokla SC; Knox DG
    Surg Gynecol Obstet; 1975 Jul; 141(1):59-68. PubMed ID: 1154215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors predicting chronic hepatic encephalopathy after distal splenorenal shunt: a multivariate analysis of clinical and hemodynamic variables.
    Spina GP; Santambrogio R; Opocher E; Pisani-Ceretti A; Ongari B; Rashidi B; Garancini P; Gallus G
    Surgery; 1993 Sep; 114(3):519-26. PubMed ID: 8367806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Calibrated latero-lateral portacaval anastomosis in the treatment of digestive hemorrhages by portal hypertension in the cirrhotic patient].
    Segol P; Auvray S; Dao T; Apoil B; Justum AM; Deshayes JP; Launoy G
    Ann Chir; 1992; 46(10):895-901. PubMed ID: 1300900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of mid- and long-term efficacy of shunt limiting for hepatic myelopathy after transjugular intrahepatic portosystemic shunt.
    Zhao H; Liu F; Yue Z; Wang L; Fan Z
    Clin Res Hepatol Gastroenterol; 2016 Sep; 40(4):440-6. PubMed ID: 26724169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.